Amgen sponsors cycling and fundraising event

Amgen has announced that it will sponsor The Dempsey Challenge: A Journey for Hope, an event aiming to raise funds for cancer research.

As well as providing support to those participating in the five-kilometre cycling fundraiser, the firm sees this as an opportunity to expand its own Breakaway from Cancer campaign.

The initiative works to raise awareness of the resources available to those with cancer, including education, patient care, advocacy and financial support.

“We are pleased to once again partner with Patrick Dempsey, a respected advocate in the fight against cancer and a long-time supporter of Amgen’s Breakaway from Cancer initiative,” explained Stuart Arbuckle, vice-president and general manager of Amgen’s oncology business department.

Last month, Amgen completed a phase III trial into the effects of Aranesp Therapy in chronic kidney disease patients with type-2 diabetes, which found that the drug had no significant effects when compared with a placebo treatment.